NuSkin Enterprises NUS
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
NuSkin Enterprises (NUS) Core Market Data and Business Metrics
Latest Closing Price
$7.22Price-Earnings Ratio
-2.45Total Outstanding Shares
49.72 Million SharesDividend
$0.06 Per Share QuarterlySIC Description
Wholesale-drugs, Proprietaries & Druggists' SundriesPrimary Exchange
New York Stock ExchangeHeadquarters
75 West Center St, Provo, UT, 84601
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
---|---|---|---|
627,978 Shares | 3.38 | 3/14/2025 | 2,125,550 Shares |
908,310 Shares | 2.41 | 2/28/2025 | 2,185,997 Shares |
850,572 Shares | 2.5 | 2/14/2025 | 2,130,397 Shares |
480,713 Shares | 5.3 | 1/31/2025 | 2,548,705 Shares |
1,099,765 Shares | 2.13 | 1/15/2025 | 2,340,017 Shares |
831,917 Shares | 1.4 | 12/31/2024 | 1,164,966 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Net Cash Flow From Investing Activities | $-37.96 Million |
Net Cash Flow From Financing Activities | $-133.18 Million |
Exchange Gains/Losses | $-9.78 Million |
Net Cash Flow From Investing Activities, Continuing | $-37.96 Million |
Net Cash Flow From Financing Activities, Continuing | $-133.18 Million |
Net Cash Flow, Continuing | $-59.40 Million |
Income Statement
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Net Income/Loss Available To Common Stockholders, Basic | $-146.59 Million |
Income Tax Expense/Benefit | $-28.46 Million |
Income/Loss From Continuing Operations After Tax | $-146.59 Million |
Operating Expenses | $1.33 Billion |
Operating Income/Loss | $-151.59 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
Comprehensive Income
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Comprehensive Income/Loss Attributable To Parent | $-171.35 Million |
Other Comprehensive Income/Loss Attributable To Parent | $-24.75 Million |
Other Comprehensive Income/Loss | $-171.35 Million |
Comprehensive Income/Loss | $-171.35 Million |
Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Other Non-current Assets | $476.44 Million |
Other Current Assets | $348.36 Million |
Other Current Liabilities | $232.95 Million |
Accounts Payable | $34.88 Million |
Intangible Assets | $74.28 Million |
Equity Attributable To Parent | $651.46 Million |
Historical Dividends
Current dividend: $0.06 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Feb 13, 2025 | Mar 5, 2025 | Feb 24, 2025 | $0.06 | Quarterly |
Nov 7, 2024 | Dec 11, 2024 | Nov 29, 2024 | $0.06 | Quarterly |
Aug 8, 2024 | Sep 11, 2024 | Aug 30, 2024 | $0.06 | Quarterly |
May 8, 2024 | Jun 12, 2024 | May 31, 2024 | $0.06 | Quarterly |
Feb 14, 2024 | Mar 6, 2024 | Feb 26, 2024 | $0.06 | Quarterly |
Nov 1, 2023 | Dec 6, 2023 | Nov 24, 2023 | $0.39 | Quarterly |